"Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial"
Publication
, Conference
De latour, RP; De Castro, CM; Szer, J; Usuki, K; Hillmen, P; Griffin, M; Hamdani, M; Ajayi, T; Nishimori, H; Weitz, IC
Published in: BRITISH JOURNAL OF HAEMATOLOGY
2021
Duke Scholars
Published In
BRITISH JOURNAL OF HAEMATOLOGY
EISSN
1365-2141
ISSN
0007-1048
Publication Date
2021
Volume
193
Start / End Page
189 / 190
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
De latour, R. P., De Castro, C. M., Szer, J., Usuki, K., Hillmen, P., Griffin, M., … Weitz, I. C. (2021). "Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial". In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 193, pp. 189–190).
De latour, Regis Peffault, Carlos M. De Castro, Jeffrey Szer, Kensuke Usuki, Peter Hillmen, Morag Griffin, Mohamed Hamdani, Temitayo Ajayi, Hisakazu Nishimori, and Ilene C. Weitz. “"Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial".” In BRITISH JOURNAL OF HAEMATOLOGY, 193:189–90, 2021.
De latour RP, De Castro CM, Szer J, Usuki K, Hillmen P, Griffin M, et al. "Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial". In: BRITISH JOURNAL OF HAEMATOLOGY. 2021. p. 189–90.
De latour, Regis Peffault, et al. “"Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial".” BRITISH JOURNAL OF HAEMATOLOGY, vol. 193, 2021, pp. 189–90.
De latour RP, De Castro CM, Szer J, Usuki K, Hillmen P, Griffin M, Hamdani M, Ajayi T, Nishimori H, Weitz IC. "Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial". BRITISH JOURNAL OF HAEMATOLOGY. 2021. p. 189–190.
Published In
BRITISH JOURNAL OF HAEMATOLOGY
EISSN
1365-2141
ISSN
0007-1048
Publication Date
2021
Volume
193
Start / End Page
189 / 190
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology